NCT05173142 2022-03-08
HMPL-453 (FGFR Inhibitor) in Combination With Chemotherapy or Anti-PD-1 Antibody in Advanced Solid Tumors
Hutchmed
Phase 1/2 Unknown
Clinical Trials
14 trialsNCT03023436 2019-09-13
Cytoreductive Surgery Combined With HIPEC and Chemotherapy for Gastric Cancer With Peritoneal Metastasis
Nanfang Hospital, Southern Medical University
Phase 3 Unknown
NCT03668418 2018-09-12
xenoZ
University of Pisa
Unknown
NCT03061058 2017-09-15
Individualized Intraperitoneal and System Chemotherapy Versus System Chemotherapy as First-line Chemotherapy for AGC
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 3 Unknown
NCT01228045 2016-06-22
A Study of Trastuzumab in Combination With TS-ONE & Cisplatin in First-line Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer
National University Hospital, Singapore
Phase 2 Unknown
NCT01679340 2015-05-19
A Phaseâ…¡ Study: SOX vs SP in Adjuvant Chemotherapy After D2 Surgery
Peking University
Phase 2 Unknown
NCT00088816 2013-09-17
S-1 and Cisplatin Before Surgery in Treating Patients With Stage IV Gastric Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01348009 2012-03-13
Tesetaxel Plus Capecitabine and Cisplatin in Advanced Gastric Cancer
Genta Incorporated
Phase 1/2 Unknown
NCT00865982 2011-08-05
DCXAIOCHARITE
Charite University, Berlin, Germany
Phase 2 Unknown
NCT01198392 2011-07-25
Trial of S-1 Plus Cisplatin in Gastric Cancer
Sun Yat-sen University
Phase 3 Unknown
NCT00178698 2011-03-03
FR-WB-TT/che
The University of Texas Health Science Center, Houston
Phase 2 Unknown
NCT00980603 2009-09-21
Docetaxel Versus Docetaxel Plus Cisplatin Versus Docetaxel Plus S-1 as Second-line Chemotherapy in Metastatic Gastric Cancer
National Cancer Center, Korea
Phase 2 Unknown
NCT00510107 2007-08-01
Weekly Docetaxel Plus Cisplatin or Oxaliplatin for AGC
Gachon University Gil Medical Center
Phase 2 Unknown
NCT00320294 2007-03-12
ILF With/Without Cisplatin for Advanced Gastric Cancer
Gachon University Gil Medical Center
Phase 2 Unknown